infliximab-dyyb
E850004
Infliximab-dyyb is a monoclonal antibody biosimilar to infliximab used to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
Statements (51)
| Predicate | Object |
|---|---|
| instanceOf |
biologic medicinal product
ⓘ
biosimilar medicinal product ⓘ monoclonal antibody ⓘ |
| administeredBy | healthcare professional ⓘ |
| belongsToTherapeuticArea |
dermatology
ⓘ
gastroenterology ⓘ rheumatology ⓘ |
| biosimilarTo | infliximab NERFINISHED ⓘ |
| contraindicatedIn |
patients with moderate or severe heart failure
ⓘ
patients with severe infections ⓘ |
| hasATCClass | L04AB02 ⓘ |
| hasBlackBoxWarning |
malignancy
ⓘ
serious infections ⓘ |
| hasDosageForm | solution for intravenous infusion ⓘ |
| hasIndication |
active ankylosing spondylitis
ⓘ
active psoriatic arthritis ⓘ chronic severe plaque psoriasis ⓘ moderate to severe Crohn’s disease ⓘ moderate to severe rheumatoid arthritis ⓘ moderate to severe ulcerative colitis ⓘ steroid-dependent Crohn’s disease ⓘ steroid-dependent ulcerative colitis ⓘ steroid-refractory Crohn’s disease ⓘ steroid-refractory ulcerative colitis ⓘ |
| hasMechanismOfAction | TNF inhibitor ⓘ |
| hasMolecularType | chimeric monoclonal antibody ⓘ |
| hasNonproprietaryName | infliximab-dyyb ⓘ |
| hasPharmacologicalClass |
immunosuppressive agent
ⓘ
tumor necrosis factor alpha inhibitor ⓘ |
| hasRouteOfAdministration |
intravenous infusion
ⓘ
parenteral ⓘ |
| hasSpeciesComponents |
human
ⓘ
mouse ⓘ |
| hasTarget |
TNF-α
NERFINISHED
ⓘ
tumor necrosis factor alpha ⓘ |
| hasUSBrandName | Inflectra NERFINISHED ⓘ |
| mayCause |
hypersensitivity reactions
ⓘ
infusion-related reactions ⓘ reactivation of latent tuberculosis ⓘ |
| regulatoryDesignation | biosimilar to Remicade ⓘ |
| requiresMonitoring |
hepatitis B virus reactivation
ⓘ
signs and symptoms of infection ⓘ tuberculosis status ⓘ |
| usedFor |
Crohn’s disease
ⓘ
ankylosing spondylitis ⓘ pediatric Crohn’s disease ⓘ pediatric ulcerative colitis ⓘ plaque psoriasis ⓘ psoriatic arthritis ⓘ rheumatoid arthritis ⓘ ulcerative colitis ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.